Krukar KM, Pustelniak M, Rudnicka K, Sajkiewicz I, Miga-Orczykowska N, Jasiuk I, et al. Clinical use of Abemaciclib a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with breast cancer — literature review. J Educ Health Sport [Internet]. 2024 Sep. 24 [cited 2024 Dec. 26];68:55282. Available from: https://apcz.umk.pl/JEHS/article/view/55282